122 - Antifungal Clinical Trials & PK/PD Studies

Moderator(s)

• 

  Joshua Nosanchuk, MD

  Professor and Senior Associate Dean
  Albert Einstein College of Medicine
  Bronx, NY, United States

  Disclosure(s): No financial relationships to disclose
• 

  Jeffrey Rybak, PharmD, PhD

  Instructor
  St. Jude Children's Research Hospital

  Disclosure(s): No financial relationships to disclose

No CE Credit Offered

Presentations:

• 10:30 AM – 10:45 AM US ET

  In Vitro Activity of Isavuconazole and Other Mould-Active Triazoles Against Aspergillus fumigatus With and Without cyp51 Alterations
  

  Co-Author: Michael A. Pfaller, MD – JMI Laboratories

  Presenting Author: Cecilia G. Carvalhaes, MD, PhD – JMI Laboratories

  Co-Author: Lalitagauri M. Deshpande, PhD – JMI Laboratories

  Co-Author: Paul Rhomberg, BS, MT(ASCP) – JMI Laboratories

  Co-Author: Mariana Castanheira, PhD – JMI Laboratories
• 10:45 AM – 11:00 AM US ET

  Oral Encochleated Amphotericin B for Cryptococcal Meningitis: a Phase II Randomized Trial
  

  Presenting Author: Mucunguzi Atukunda, MBChB, MPH – Infectious Diseases Institute, Makerere University

  Co-Author: Enock Kagimu, MBChB – Infectious Diseases Institute, Makerere University

  Co-Author: Morris K. Rutakingirwa, MBChB – Infectious diseases institute, College of health sciences, Makerere University, Kampala Uganda

  Co-Author: Lillian Tugume, MBChB, MPH – Infectious Diseases Institute, Makerere University

  Co-Author: Laura Nsangi, MBChB – Infectious Diseases Institute, Makerere University

  Co-Author: Abdu Musubire, MBChB, MMed – Infectious Diseases Institute, Makerere University

  Co-Author: Jane Gakuru, MBChB – Infectious Diseases Institute, Makerere University

  Co-Author: Timothy Mugabi, MBChB – Infectious Diseases Institute, Makerere University

  Co-Author: Andrew Akampurira, n/a – Infectious Diseases Institute, Makerere University

  Co-Author: Kenneth Ssebambulidde, MBChB – Infectious Diseases Institute, Makerere University

  Co-Author: John Kasibante, MBChB – Infectious Diseases Institute, Makerere University

  Co-Author: Jayne Ellis, MD – Infectious Diseases Institute, Makerere University

  Co-Author: Edward Mpoza, MBChB, MMed – Infectious Diseases Institute, Makerere University

  Co-Author: Darlisha A. Williams, n/a – University of Minnesota

  Co-Author: Ann M. Fieberg, M.S. – University of Minnesota

  Co-Author: Caleb Skipper, MD – University of Minnesota

  Co-Author: Mahsa Abassi, MD – University of Minnesota

  Co-Author: Kathy Huppler Hullsiek, n/a – University of Minnesota

  Co-Author: David Meya, MBChB, MMed, PhD – Infectious Diseases Institute, Makerere University

  Co-Author: David R. Boulware, MD, MPH, CTropMed – University of Minnesota
• 11:00 AM – 11:15 AM US ET

  Olorofim for the treatment of invasive mould infections in patients with limited or no treatment options: Comparison of interim results from a Phase 2B open-label study with outcomes in historical control populations (NCT03583164, FORMULA-OLS, Study 32)
  

  Presenting Author: Johan A. Maertens, MD PhD – KU Leuven

  Co-Author: Paul E. Verweij, PhD – Radboud University Medical Center

  Co-Author: Evan F. Lanuza, n/a – Kern Medical

  Co-Author: Emma L. Harvey, MBBS – F2G Ltd

  Co-Author: Aaron Dane, MSc – Danestat Consulting Limited

  Co-Author: Daniela Zinzi, Infectious Diseases Specialist – F2G

  Co-Author: John H. Rex, MD – F2G, Limited

  Co-Author: Sharon C. Chen, PhD MBBS – Westmead Hospital
• 11:15 AM – 11:30 AM US ET

  Oral Ibrexafungerp Outcomes by Fungal Disease in Patients from an Interim Analysis of a Phase 3 Open-label Study (FURI)
  

  Presenting Author: George R. Thompson, III, MD – University of California Davis Medical Center

  Co-Author: Thomas King, MS MPH – SCYNEXIS, Inc.

  Co-Author: Nkechi Azie, MD MBA FIDSA – SCYNEXIS, Inc.

  Co-Author: David A. Angulo, MD – SCYNEXIS, Inc.

  Co-Author: Juergen Prattes, MD, FECMM – Medical University of Graz
• 11:30 AM – 11:45 AM US ET

  Voriconazole Therapeutic Drug Monitoring (TDM): How Common is Autoinduction?
  

  Co-Author: Varalika Tyagi, n/a – University of Alberta

  Co-Author: Cecilia Lau, BScPharm, ACPR – Alberta Health Services

  Co-Author: Karen Doucette, MD, MSc – University of Alberta

  Co-Author: Carlos Cervera, Associate Professor – University of Alberta

  Presenting Author: Dima Kabbani, MD, MSc (she/her/hers) – University of Alberta